-+ 0.00%
-+ 0.00%
-+ 0.00%

Newbury Pharmaceuticals signs 10-year exclusivity deal for 40-product hospital portfolio in Iraq

PUBT·09/28/2026 12:01:39
Listen to the news
Newbury Pharmaceuticals signs 10-year exclusivity deal for 40-product hospital portfolio in Iraq
  • Newbury Pharmaceuticals entered a 10-year exclusivity agreement with a Chinese drug manufacturer covering a 40-product hospital portfolio in Iraq.
  • Deal grants exclusive rights to register, market, sell products in Iraq under Newbury labels, targeting acute care and injectable medicines.
  • Portfolio centers on anti-infectives, pain and surgical-support drugs, gastroenterology injectables, supportive care products for hospital tenders, private channels.
  • Newbury applied for an Iraqi import license that could enable limited early supply ahead of full marketing authorizations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Newbury Pharmaceuticals AB published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.